Liver biopsy performance and histological findings among patients with chronic viral hepatitis: A Danish database study

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 3, 2007, Pages 245-249

  Christensen, Peer Brehm ^a   Krarup, Henrik Bygum ^b   Møller, Axel ^c   Laursen, Alex Lund ^d   Kjaer, Mette ^e   Orholm, Marianne ^f   Lindberg, Jens ^g   Groenbaek, Karin ^h   Kromann Andersen, Hans ⁱ   Weis, Nina ^h  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c KOLDING HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Elsinore Hospital   (Denmark)

^g HERNING HOSPITAL   (Denmark)

^h HVIDOVRE HOSPITAL   (Denmark)

ⁱ KØGE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DENMARK; DISEASE DURATION; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION;

ADULT; ALANINE TRANSAMINASE; BIOPSY; DENMARK; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; REGISTRIES;

EID: 33847289669     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600978864     Document Type: Article

References (20)

1. Gjorup, IE,.Smith, E.,.Borgwardt, L. and Skinhoj, P. (2003) 20-y survey of the epidemiology of hepatitis B in Denmark: Effect of immigration. Scand J Infect Dis, 35, pp. 260-264.
2. Weis, NM,.Christensen, PB and Laursen, AL. (2006) Treatment of chronic hepatitis C. The Danish Society of Infection Medicine. Ugeskr Laeger, 168, p. 1221.
3. Puoti, C.,.Guido, M.,.Mangia, A.,.Persico, M. and Prati, D. (2003) Clinical management of HCV carriers with normal aminotransferase levels. Dig Liver Dis, 35, pp. 362-369.
4. NIH, Consensus Statement on Management of Hepatitis C. (2002) NIH Consens State Sci Statement, 19, pp. 1-46.
5. Dhumeaux, D.,.Marcellin, P. and Lerebours, E. (2003) Treatment of hepatitis C. The 2002 French consensus. Gut, 52, pp. 1784-1787.
6. Bedossa, P. and Poynard, T. (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, pp. 289-293.
7. Zheng, M.,.Cai, WM,.Weng, HL and Liu, RH. (2002) ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol, 8, pp. 1073-1076.
8. Strader, DB,.Wright, T.,.Thomas, DL and Seeff, LB. (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology, 39, pp. 1147-1171.
9. Gronbaek, K.,.Christensen, PB,.Hamilton-Dutoit, S.,.Federspiel, BH,.Hage, E. and Jensen, OJ (2002) Inter-observer variation in interpretation of serial liver biopsies from patients with chronic hepatitis C. J Viral Hepat, 9, pp. 443-449.
10. Poynard, T.,.Bedossa, P. and Opolon, P. (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet, 349, pp. 825-832.
11. Hollander, A.,.Glaumann, H. and Weiland, O. (2004) Histological findings, genotype distribution and percentage of patients fulfilling the treatment criteria among patients with chronic hepatitis C virus infection in a single Swedish centre. Scand J Gastroenterol, 39, pp. 164-167.
12. Gronbaek, K.,.Krarup, HB,.Moller, H.,.Krogsgaard, K.,.Franzmann, M. and Sonne, J. (1999) Natural history and aetiology of liver disease in patients with previous community-acquired acute non-A, non-B hepatitis. A follow-up study of 178 Danish patients consecutively enrolled in The Copenhagen Hepatitis Acuta Programme in the period 1969-1987. J Hepatol, 31, pp. 800-807.
13. Seeff, LB. (1997) Natural history of hepatitis C. Hepatology, 26, p. S21.
14. Afdhal, NH. (2004) The natural history of hepatitis C. Semin Liver Dis, 24, pp. 3-8.
15. Marcellin, P.,.Asselah, T. and Boyer, N. (2002) Fibrosis and disease progression in hepatitis C. Hepatology, 36, p. S47.
16. Myers, RP,.Ratziu, V.,.Imbert-Bismut, F.,.Charlotte, F. and Poynard, T. (2002) Biochemical markers of liver fibrosis: A comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol, 97, pp. 2419-2425.
17. Mathurin, P.,.Moussalli, J.,.Cadranel, JF,.Thibault, V.,.Charlotte, F. and Dumouchel, P. (1998) Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology, 27, pp. 868-872.
18. Nutt, AK,.Hassan, HA,.Lindsey, J.,.Lamps, LW and Raufman, JP. (2000) Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels. Am J Med, 109, pp. 62-64.
19. Pradat, P.,.Alberti, A.,.Poynard, T.,.Esteban, JI,.Weiland, O. and Marcellin, P. (2002) Predictive value of ALT levels for histological findings in chronic hepatitis C: A European collaborative study. Hepatology, 36, pp. 973-977.
20. Puoti, C.,.Magrini, A.,.Stati, T.,.Rigato, P.,.Montagnese, F. and Rossi, P. (1997) Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology, 26, pp. 1393-1398.